To investigate the use of streptavidin-hapten derivatives as potential protein-tracer conjugates for competitivetype immunoassays, we labeled streptavidin with cortisol and compared biotin-binding activity of the conjugates with that of unlabeled streptavidin. In this model system, streptavidin labeled with one to ---17 cortisol molecules retained its capability to cross-link a biotinylated protein on microtiter wells to a biotin-based general detection reagent developed for time-resolved fluorometry. Compared with unlabeled streptavidin, there was no reduction in the binding activity of the conjugate carrying as many as 2.6 cortisol molecules per molecule of streptavidin.
To investigate the use of streptavidin-hapten derivatives as potential protein-tracer conjugates for competitivetype immunoassays, we labeled streptavidin with cortisol and compared biotin-binding activity of the conjugates with that of unlabeled streptavidin. In this model system, streptavidin labeled with one to ---17 cortisol molecules retained its capability to cross-link a biotinylated protein on microtiter wells to a biotin-based general detection reagent developed for time-resolved fluorometry. Compared with unlabeled streptavidin, there was no reduction in the binding activity of the conjugate carrying as many as 2.6 cortisol molecules per molecule of streptavidin.
Conjugation ratios >4.4 showed a slight decrease in binding activity, presumably because of the aggregate formation evident at these labeling ratios. As expected, the conjugates were also capable of linking a solid-phasebound anti-cortisol monoclonal antibody to the biotinylated detection reagent. The fluorescence signal generated increased almost linearly with increasing conjugation ratios from about three to nine cortisol molecules per molecule of streptavidin. At greater ratios, the assay response plateaued. The calibration curves obtained were typical for competitive-type immunoassays when the conjugates were incorporated in a cortisol assay based on a second-antibody immobilization approach. receptors, membrane antigens, and DNA fragments (2, 3) and has been successful in applications involving visualization and characterization of cell surface receptors and interacellular components by light and fluorescence microscopy (2, 4, 5). By the use of appropriate biotin-avidin derivatives, selective staining of various functional groups of membrane proteins and glycoproteins has been also possible (6) . Electron-dense derivatives of avidin have been used to expand applications of electron microscopy in ultrastructural visualization of specific cellular components (7, 8) (20, 21 Buffers. The coating buffer was 10 Monoclonal antibody. The anti-cortisol monoclonal antibody was purchased from Medix Biotech, Inc., Foster City, CA 94404. Comparison method. The FIAgenTM cortisol fluoroimmunoassay (CyberFluor, Inc.) (23) was used for comparison.
Specimens. 
Results

Evaluation of Streptavidin-Cortisol Conjugate
Binding activity. We tested the ability of streptavidun to bridge two biotinylated proteins (1) to determine the effect of conjugation on the binding activity of the protein.
We labeled streptavidin with cortisol at increasing molar ratios and compared equal amounts of the labeled and unlabeled protein for cross-linking solid-phase-bound biotin to a biotinylated detection reagent. As represented in Table 1 
Analytical Variables
A typical standard curve for the assay is shown in Figure 2 . The detection limit, defined as the analyte 
Discussion
Application of the biotin-avidin system in analytical methods based on both immunological and nonimmunological principles is well documented.
In the immunoassay field, the system has been used successfully to develop separation methods involving solid-phasebound avidin (16, 17) , and in the design of highly sensitive and versatile detection reagents with use of biotinylated immunoreactant and streptavidin-(or avidin-) based detection probes. The latter has involved both isotopic (17, 18) and nonisotopic (10, 14, 20) After labeling, dialysis of the reaction mixture is sufficient to remove unwanted species.
In the present investigation, we found that streptavidin labeled with as many as 17 cortisol molecules could still maintain its biological activity for biotin. The observed decrease in the binding activity of the conjugates labeled with 4.4 molecules of cortisol may be due in part to aggregate formation evident at these labeling ratios. The loss appeared unrelated to protein recovery, which began to decrease at incorporations > -11 cortisol molecules per molecule of streptavidin.
